TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical
US Patent
Senju Pharmaceutical
US Patent
Affinity DataIC50: 5.80nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair